291 related articles for article (PubMed ID: 30573406)
1. Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Zhu XM; Zhang QE; Yang XH; Cai DB; Li L; Li XB; Ng CH; Ungvari GS; Ning YP; Xiang YT
Schizophr Res; 2019 Apr; 206():13-20. PubMed ID: 30573406
[TBL] [Abstract][Full Text] [Related]
2. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S
CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Li XH; Yang XH; Cai DB; Ungvari GS; Ng CH; Wang SB; Wang YY; Ning YP; Xiang YT
Psychol Med; 2018 Jan; 48(1):72-81. PubMed ID: 28528597
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Cai DB; Yang XH; Ungvari GS; Ng CH; Müller N; Ning YP; Xiang YT
J Psychiatr Res; 2017 Sep; 92():139-146. PubMed ID: 28445800
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials.
Xiang YQ; Zheng W; Wang SB; Yang XH; Cai DB; Ng CH; Ungvari GS; Kelly DL; Xu WY; Xiang YT
Eur Neuropsychopharmacol; 2017 Jan; 27(1):8-18. PubMed ID: 27919523
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive ondansetron for schizophrenia: A systematic review and meta-analysis of randomized controlled trials.
Zheng W; Cai DB; Zhang QE; He J; Zhong LY; Sim K; Ungvari GS; Ning YP; Xiang YT
J Psychiatr Res; 2019 Jun; 113():27-33. PubMed ID: 30878789
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive raloxifene for postmenopausal women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Zhu XM; Zheng W; Li XH; Cai DB; Yang XH; Ungvari GS; Ng CH; Wang XP; Kulkarni J; Grigg J; Ning YP; Xiang YT
Schizophr Res; 2018 Jul; 197():288-293. PubMed ID: 29395611
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials.
Oya K; Matsuda Y; Matsunaga S; Kishi T; Iwata N
Eur Arch Psychiatry Clin Neurosci; 2016 Aug; 266(5):439-50. PubMed ID: 26303414
[TBL] [Abstract][Full Text] [Related]
9. Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials.
Correll CU; Maayan L; Kane J; Hert MD; Cohen D
J Clin Psychiatry; 2016 Jun; 77(6):e746-56. PubMed ID: 27337425
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials.
Zheng W; Li XB; Shi ZM; Yang XH; Cai DB; Ng CH; Ungvari GS; Liu WJ; Wu YJ; Wang YY; Ning YP; Xiang YT
Pharmacopsychiatry; 2020 Jan; 53(1):5-13. PubMed ID: 31207653
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials.
Zheng W; Xiang YT; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Correll CU
Acta Psychiatr Scand; 2016 Nov; 134(5):385-398. PubMed ID: 27585549
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive azapirone for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Li XH; Cai DB; Yang XH; Ungvari GS; Ng CH; Ning YP; Xiang YT
Eur Neuropsychopharmacol; 2018 Jan; 28(1):149-158. PubMed ID: 29174529
[TBL] [Abstract][Full Text] [Related]
13. Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia.
Solmi M; Veronese N; Thapa N; Facchini S; Stubbs B; Fornaro M; Carvalho AF; Correll CU
CNS Spectr; 2017 Oct; 22(5):415-426. PubMed ID: 28181901
[TBL] [Abstract][Full Text] [Related]
14. Amantadine for Antipsychotic-Related Weight Gain: Meta-Analysis of Randomized Placebo-Controlled Trials.
Zheng W; Wang S; Ungvari GS; Ng CH; Yang XH; Gu YH; Li M; Xiang YQ; Xiang YT
J Clin Psychopharmacol; 2017 Jun; 37(3):341-346. PubMed ID: 28383359
[TBL] [Abstract][Full Text] [Related]
15. Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia.
Lee MR; Wehring HJ; McMahon RP; Liu F; Linthicum J; Verbalis JG; Buchanan RW; Strauss GP; Rubin LH; Kelly DL
Schizophr Res; 2016 Apr; 172(1-3):165-8. PubMed ID: 26879587
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
Oya K; Kishi T; Iwata N
Hum Psychopharmacol; 2014 Sep; 29(5):483-91. PubMed ID: 25087702
[TBL] [Abstract][Full Text] [Related]
17. Short-term efficacy and tolerability of lurasidone in the treatment of acute schizophrenia: A meta-analysis of randomized controlled trials.
Zheng W; Cai DB; Yang XH; Li L; Zhang QE; Ng CH; Ungvari GS; Li XB; Ning YP; Xiang YT
J Psychiatr Res; 2018 Aug; 103():244-251. PubMed ID: 29906709
[TBL] [Abstract][Full Text] [Related]
18. Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis.
Sakuma K; Matsunaga S; Nomura I; Okuya M; Kishi T; Iwata N
Psychopharmacology (Berl); 2018 Aug; 235(8):2303-2314. PubMed ID: 29785555
[TBL] [Abstract][Full Text] [Related]
19. Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis.
Beck K; Hindley G; Borgan F; Ginestet C; McCutcheon R; Brugger S; Driesen N; Ranganathan M; D'Souza DC; Taylor M; Krystal JH; Howes OD
JAMA Netw Open; 2020 May; 3(5):e204693. PubMed ID: 32437573
[TBL] [Abstract][Full Text] [Related]
20. Estradiol and raloxifene as adjunctive treatment for women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Li Z; Wang Y; Wang Z; Kong L; Liu L; Li L; Tang Y
Acta Psychiatr Scand; 2023 Apr; 147(4):360-372. PubMed ID: 36585771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
